Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma

NCT06530784 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Hepatocellular

Interventions

PROCEDURE: Cryoablation
DRUG: PD-1 antibody and bevacizumab

Sponsor

Shanghai Zhongshan Hospital